Beijing Biological Zhipin Research Institute Co., Ltd.

北京生物制品研究所有限责任公司
Get registeredChina • Asia
Not yet registered on PMX
This profile is generated from public regulatory records. The company has not registered on PMX yet, and PMX has not verified it.
Country
China
Region
Asia

Regulatory licences

  • DPL
    Name on licence: 北京生物制品研究所有限责任公司

Registered products

53 products
InjectionZhongzuyixingganyanyimiao重组乙型肝炎疫苗(酿酒酵母)每支0.5ml。每1次人用剂量0.5ml,含HBsAg10μg。InjectionZhongzuyixingganyanyimiao重组乙型肝炎疫苗(酿酒酵母)每支1.0ml。每1次人用剂量1.0ml,含HBsAg20μg。Oral solutionKoufujisuihuizhiyanjianduhuoyimiao口服脊髓灰质炎减毒活疫苗(人二倍体细胞)每瓶1.0ml。每1次人用剂量为2滴(相当于0.1ml),所含脊髓灰质炎活病毒总量应不低于6.25lgCCID50,其中I型应不低于6.0lgCCID50,Ⅱ型应不低于5.0lgCCID50,Ⅲ型应不低于5.8lgCCID50。Oral solutionKoufuIxingIIIxingjisuihuizhiyanjianduhuoyimiao口服Ⅰ型Ⅲ型脊髓灰质炎减毒活疫苗(人二倍体细胞)每瓶1.0ml(10人份)。每1次人用剂量为2滴(相当于0.1ml),含脊髓灰质炎活病毒总量应不低于6.12lgCCID50,其中Ⅰ型应不低于6.0lgCCID50,Ⅲ型应不低于5.5lgCCID50。Oral solutionKoufuIxingIIIxingjisuihuizhiyanjianduhuoyimiao口服Ⅰ型Ⅲ型脊髓灰质炎减毒活疫苗(人二倍体细胞)每瓶2.0ml(20人份)。每1次人用剂量为2滴(相当于0.1ml),含脊髓灰质炎活病毒总量应不低于6.12lgCCID50,其中Ⅰ型应不低于6.0lgCCID50,Ⅲ型应不低于5.5lgCCID50。InjectionSabinzhujisuihuizhiyanmiehuoyimiaoSabin株脊髓灰质炎灭活疫苗(Vero细胞)每瓶0.5ml。每1次人用剂量0.5ml,含脊髓灰质炎病毒抗原量为Ⅰ型15DU,Ⅱ型45DU,Ⅲ型45DU。Oral solutionKoufuIxingIIIxingjisuihuizhiyanjianduhuoyimiao口服Ⅰ型Ⅲ型脊髓灰质炎减毒活疫苗(人二倍体细胞)每瓶0.5ml(5人份)。每1次人用剂量为2滴(相当于0.1ml),含脊髓灰质炎活病毒总量应不低于6.12lgCCID50,其中Ⅰ型应不低于6.0lgCCID50,Ⅲ型应不低于5.5lgCCID50。InjectionXinxingguanzhuangbingdumiehuoyimiao新型冠状病毒灭活疫苗(Vero 细胞)0.5mL/支。每1次人用剂量0.5mL,含灭活新型冠状病毒抗原6.5U。InjectionXinxingguanzhuangbingdumiehuoyimiao新型冠状病毒灭活疫苗(Vero 细胞)0.5mL/瓶。每1次人用剂量0.5mL,含灭活新型冠状病毒抗原6.5U。InjectionXinxingguanzhuangbingdumiehuoyimiao新型冠状病毒灭活疫苗(Vero 细胞)1.0mL/瓶(2次人用剂量),含灭活新型冠状病毒抗原13U。InjectionXinxingguanzhuangbingdumiehuoyimiao新型冠状病毒灭活疫苗(Vero 细胞)2.5mL/瓶(5次人用剂量),含灭活新型冠状病毒抗原32.5U。InjectionACYW135qunnaomoyanqiujunduotangyimiaoACYW135群脑膜炎球菌多糖疫苗复溶后每瓶0.5mL。每1次人用剂量0.5mL,含A群、C群、Y群、W135群多糖各50μg。